Dr. Ajai Chari completed his medical degree at the UCLA School of Medicine. His clinical focus is on patients with multiple myeloma and other plasma cell disorders, and he has also published and lectured extensively on topics relating to these diseases. Dr Chari is involved in several clinical trials investigating new drug regimens, and he oversees a program that played a pivotal role in the approval of the five newest drugs used for the treatment of multiple myeloma. Dr. Chari is Professor of Medicine, Director of Clinical Research in the Multiple Myeloma Program, and Associate Director of Clinical Research at the Mt. Sinai Cancer Clinical Trials Office in New York, New York
Dr. Hira Mian Dr. Hira Mian is currently an assistant professor at Juravinski Cancer Center and is the lead for the plasma group at the site. She completed her training between University of Toronto and McMaster University and her graduate work and clinical investigator program at McMaster. Her clinical and research interests are in multiple myeloma, geriatric oncology, and health services and outcomes
For more information, please send requests to Robyn Leonard at firstname.lastname@example.org.